Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of 4–20 ng/ml
Open Access
- 15 March 1997
- journal article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 37 (5), 1053-1058
- https://doi.org/10.1016/s0360-3016(96)00633-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Prostate cancer and radiation therapy—The message conveyed by serum prostate-specific antigenInternational Journal of Radiation Oncology*Biology*Physics, 1995
- A Multivariate Analysis of Clinical and Pathological Factors that Predict for Prostate Specific Antigen Failure after Radical Prostatectomy for Prostate CancerJournal of Urology, 1995
- Prostate-specific antigen for pretreatment prediction and posttreatment evaluation of outcome after definitive irradiation for prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Prostate Specific Antigen Following Radiotherapy for Local Prostate CancerJournal of Urology, 1995
- Radical prostatectomy for adenocarcinoma of the prostate: The influence of preoperative and pathologic findings on biochemical disease-free outcomeUrology, 1994
- Results of Conservative Management of Clinically Localized Prostate CancerNew England Journal of Medicine, 1994
- Prostatic specific antigen confirmation of long term cure of prostate cancer treated by external beam radiation in the RTOGInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Prostate-specific antigen to determine progression-free survival after radiation therapy for localized carcinoma of prostateUrology, 1993
- More on the uro-oncology research group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958